CORRESP 1 filename1.htm s22-9153_corresp.htm
Alston & Bird LLP
90 Park Avenue
New York, NY 10016

212-210-9400
Fax:212-210-9444
www.alston.com

 
 Timothy P. Selby  
 Direct Dial: 212-210-9494
 E-mail: tim.selby@alston.com
 


VIA           EDGAR & OVERNIGHT DELIVERY

100 F Street N.E.
Washington, D.C. 20549-3651
Attn: Mr. Philip L. Rothenberg, Mail Stop 3010

 
Re:
Post-Effective Amendment No. 4 to Form S-1
Filed on April 3, 2009
File No. 333-146177

 
 
Comment #1
 
We note that you have requested confidential treatment of portions of a certain material agreement filed with the Commission. Please be advised that comments, if any, to this confidential treatment request will be forthcoming in a separate letter. If we issue any comments to this confidential treatment request, we will act upon any request for acceleration of the effective date of the Form S-1 and, pursuant to delegated authority, grant acceleration of the effective date only after you have complied with our comments.
 
Response #1
 
On April 22, 2009, we were advised, via telephone, by Mr. Rothenberg that the request for confidential treatment was granted for the above-referenced filing (File No. 0-22887 - CF#23436).
 



 

Atlanta • Charlotte • Dallas • Los Angeles • New York • Research Triangle • Silicon Valley • Ventura County • Washington, D.C.
 
 

 
United States Securities and Exchange Commission
April 27, 2009
Page 2



Comment #2
 
You disclose that you incorporate by reference into the prospectus certain documents listed on page 9, including exhibits, “except to the extent information in those documents differs from information contained in this prospectus.” Please explain to us what this phrase means and why you have included this language in the prospectus.
 
Response #2
 
The Registrant will remove the above-referenced language from page 9 of the prospectus prior to printing the prospectus.  A final copy of the prospectus will be filed with the Commission pursuant to Rule 424(b) immediately after the prospectus has been declared effective.
 

 
Additionally, pursuant to your request, this letter constitutes an acknowledgement on behalf of the Managing Owner and the Registrant that:
 
 
1.
should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
 
 
2.
the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
 
 
3.
the Registrant may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
 

 


/s/ Timothy P. Selby                                                      


ALP:alp
cc:
Ms. Kimberly Lynch, R.J. O’Brien Fund Management, LLC